LifeVantage (LFVN) News Today $16.69 -0.09 (-0.54%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$16.10 -0.60 (-3.57%) As of 02/21/2025 06:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Empowered Funds LLC Sells 29,999 Shares of LifeVantage Co. (NASDAQ:LFVN)Empowered Funds LLC reduced its holdings in LifeVantage Co. (NASDAQ:LFVN - Free Report) by 38.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 48,860 shares of the company's stock after selling 29,999February 18, 2025 | marketbeat.comInsider Selling: LifeVantage Co. (NASDAQ:LFVN) Director Sells 8,000 Shares of StockFebruary 13, 2025 | insidertrades.comRaymond B. Greer Sells 8,000 Shares of LifeVantage Co. (NASDAQ:LFVN) StockLifeVantage Co. (NASDAQ:LFVN - Get Free Report) Director Raymond B. Greer sold 8,000 shares of LifeVantage stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $20.15, for a total transaction of $161,200.00. Following the sale, the director now owns 99,288 shares in the company, valued at approximately $2,000,653.20. The trade was a 7.46 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.February 12, 2025 | marketbeat.comLifeVantage (LFVN) Gets a Buy from Craig-HallumFebruary 12, 2025 | markets.businessinsider.comGLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss Trends (LFVN)GLP-1 weight loss drugs are in short supply enabling lab to make compounded GLP-1 treatments sold for 80% less than the name-brand drugs.February 12, 2025 | marketbeat.comLifeVantage (NASDAQ:LFVN) Is Paying Out A Dividend Of $0.04February 9, 2025 | uk.finance.yahoo.comLake Street Keeps Their Buy Rating on LifeVantage (LFVN)February 6, 2025 | markets.businessinsider.comCraig-Hallum Sticks to Their Buy Rating for LifeVantage (LFVN)February 6, 2025 | markets.businessinsider.comLifevantage trading halted, volatility trading pauseFebruary 6, 2025 | markets.businessinsider.comLifeVantage Corporation (LFVN) Q2 2025 Earnings Call TranscriptFebruary 5, 2025 | seekingalpha.comLifeVantage Co. (NASDAQ:LFVN) Announces $0.04 Quarterly DividendLifeVantage Co. (NASDAQ:LFVN) announced a quarterly dividend on Wednesday, February 5th. Investors of record on Monday, March 3rd will be paid a dividend of 0.04 per share on Monday, March 17th. This represents a $0.16 dividend on an annualized basis and a yield of 0.70%.February 5, 2025 | marketbeat.comLifeVantage (NASDAQ:LFVN) Issues Earnings Results, Beats Expectations By $0.08 EPSLifeVantage (NASDAQ:LFVN - Get Free Report) released its earnings results on Wednesday. The company reported $0.22 earnings per share for the quarter, beating analysts' consensus estimates of $0.14 by $0.08. LifeVantage had a net margin of 2.11% and a return on equity of 29.24%.February 5, 2025 | marketbeat.com2LFVN : Lifevantage: Q2 Earnings InsightsFebruary 5, 2025 | benzinga.comLifeVantage completes study of MB System on activating GLP-1 productionFebruary 5, 2025 | markets.businessinsider.comLifeVantage Announces Financial Results for the Second Quarter of Fiscal 2025February 5, 2025 | markets.businessinsider.comEarnings call transcript: LifeVantage Q2 2024 beats forecasts, stock dipsFebruary 5, 2025 | msn.comLifeVantage Declares Quarterly DividendFebruary 5, 2025 | globenewswire.comLifeVantage announces completion of international in vitro study on MB SystemFebruary 4, 2025 | markets.businessinsider.comLifeVantage reports positive results from GLP-1 studyFebruary 4, 2025 | msn.comLifeVantage Announces Completion of International In Vitro Study on the MB System™February 4, 2025 | markets.businessinsider.comShould You Investigate LifeVantage Corporation (NASDAQ:LFVN) At US$22.40?January 31, 2025 | finance.yahoo.comShould You Investigate LifeVantage Corporation (NASDAQ:LFVN) At US$22.40?January 31, 2025 | finance.yahoo.comLifeVantage (LFVN) Projected to Post Earnings on WednesdayLifeVantage (NASDAQ:LFVN) will be releasing earnings after the market closes on Wednesday, February 5, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=658410)January 29, 2025 | marketbeat.comLifeVantage (LFVN) Projected to Post Earnings on TuesdayLifeVantage (NASDAQ:LFVN) will be releasing earnings before the market opens on Tuesday, January 28, Financial Modeling Prep reports.January 23, 2025 | marketbeat.comLifeVantage to Announce Second Quarter Fiscal Year 2025 Results on February 5, 2025January 22, 2025 | globenewswire.comTrueScience® Activated Skincare Collection Recognized for Cutting-Edge Innovation, Clean Beauty Standards, and Proven Anti-Aging Results*January 21, 2025 | uk.finance.yahoo.comRitholtz Wealth Management Buys 18,682 Shares of LifeVantage Co. (NASDAQ:LFVN)Ritholtz Wealth Management lifted its stake in shares of LifeVantage Co. (NASDAQ:LFVN - Free Report) by 65.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 47,348 shares of the company's stock after buyinJanuary 20, 2025 | marketbeat.comShort Interest in LifeVantage Co. (NASDAQ:LFVN) Drops By 5.4%LifeVantage Co. (NASDAQ:LFVN - Get Free Report) saw a large drop in short interest during the month of December. As of December 31st, there was short interest totalling 191,800 shares, a drop of 5.4% from the December 15th total of 202,800 shares. Currently, 1.9% of the shares of the company are sold short. Based on an average daily trading volume, of 110,600 shares, the days-to-cover ratio is currently 1.7 days.January 19, 2025 | marketbeat.comBarclays PLC Raises Stock Holdings in LifeVantage Co. (NASDAQ:LFVN)Barclays PLC lifted its stake in LifeVantage Co. (NASDAQ:LFVN - Free Report) by 38.2% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 41,966 shares of the company's stock after buying an additional 11,608 shares during thJanuary 18, 2025 | marketbeat.comLifeVantage appoints Thompson as Chief Information, Innovation OfficerJanuary 16, 2025 | markets.businessinsider.comLifeVantage Corporation: LifeVantage Welcomes Todd Thompson as Chief Information and Innovation OfficerJanuary 16, 2025 | finanznachrichten.deLifeVantage appoints new Chief Information and Innovation OfficerJanuary 16, 2025 | msn.comLifeVantage Welcomes Todd Thompson as Chief Information and Innovation OfficerJanuary 16, 2025 | globenewswire.comCraig-Hallum Initiates Coverage of LifeVantage (LFVN) with Buy RecommendationJanuary 15, 2025 | msn.comCraig-Hallum bullish on LifeVantage, initiates with a BuyJanuary 14, 2025 | markets.businessinsider.comLifeVantage initiated with a Buy at Craig-HallumJanuary 14, 2025 | msn.comLifeVantage (NASDAQ:LFVN) Now Covered by Analysts at Craig HallumCraig Hallum assumed coverage on shares of LifeVantage in a research note on Tuesday. They issued a "buy" rating and a $35.00 price objective for the company.January 14, 2025 | marketbeat.comLifeVantage launches 2025 vision with ‘Drive ERA’January 14, 2025 | markets.businessinsider.comLifeVantage announces results of third-party cell study of health weight stackJanuary 14, 2025 | markets.businessinsider.comLifeVantage Study Confirms Breakthrough Synergistic Effects of Healthy Weight Stack*January 13, 2025 | markets.businessinsider.comLifeVantage Launches 2025 Vision with “Drive ERA” Theme and International Expansion Plans for Evolve Compensation Plan and the MindBody GLP-1 System™January 13, 2025 | globenewswire.comLifeVantage price target raised to $30 from $26 at Lake StreetJanuary 11, 2025 | markets.businessinsider.comLifeVantage: Bold Move Into The GLP-1 Weight Loss Market Turns Out To Be A Major Winner - BuyJanuary 9, 2025 | seekingalpha.comLifeVantage Preliminary Q2 Revenue Climbs, Lifts Annual Revenue Outlook; Pre-Market Stock Up 31%January 8, 2025 | markets.businessinsider.comLifeVantage Shares Rise 30% After 2025 Revenue Outlook ImprovesJanuary 8, 2025 | marketwatch.comLifeVantage Announces Preliminary Second Quarter Revenue Results and Raises Fiscal 2025 Revenue GuidanceJanuary 8, 2025 | finance.yahoo.comLifeVantage raises FY25 revenue view $235M-$245M from $200M-$210MJanuary 8, 2025 | markets.businessinsider.comLake Street Remains a Buy on LifeVantage (LFVN)January 8, 2025 | markets.businessinsider.comLifeVantage soars after seeing a sales boost from its GLP-1 productJanuary 8, 2025 | msn.comLifeVantage to Participate in the 27th Annual ICR ConferenceJanuary 6, 2025 | globenewswire.com Get LifeVantage News Delivered to You Automatically Sign up to receive the latest news and ratings for LFVN and its competitors with MarketBeat's FREE daily newsletter. Email Address LFVN Media Mentions By Week LFVN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LFVN News Sentiment▼1.670.60▲Average Medical News Sentiment LFVN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LFVN Articles This Week▼12▲LFVN Articles Average Week Get LifeVantage News Delivered to You Automatically Sign up to receive the latest news and ratings for LFVN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Pharvaris News Today ArriVent BioPharma News Today Cogent Biosciences News Today Oculis News Today Bicycle Therapeutics News Today Ginkgo Bioworks News Today Immunome News Today Avadel Pharmaceuticals News Today CureVac News Today Avid Bioservices News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LFVN) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeVantage Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeVantage With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.